Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva Pharmaceutical Stock Could Double | Barron's
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Drugmaker Teva makes $40B bid for rival Mylan
Teva's New CEO to Cut 25% of Jobs to Rescue Ailing Drugmaker | Fortune
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Adderall hard to find at pharmacies after labor shortage at U.S. supplier
U.S. charges Teva in generic drugs price-fixing probe
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva, Allergan reach $107 million deal with Rhode Island over opioid crisis
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva attracts attention from pharma, private equity for $500M sale of Medis: Bloomberg | Fierce Pharma
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
